Robbi competes sucessfully for the prestigious F31 fellowship from NIH Figure 1. The potential interactions between microglia…

Nature Cancer - Ubellacker and Dixon summarize the latest discoveries on ferroptosis in cancer, covering the molecular and cellular pathways underlying sensitivity and resistance to this type of...

Yet an even more important ally is the American people. The American people have for many decades given us great gifts — decades of generous support for research, as well as young people to educate an...

Rathmell, a pioneer in immune and cancer cell metabolism research, has been named Chair of the Ben May Department for Cancer Research and Director of the Ludwig Center for Metastasis Research at the University of Chicago, effective July 1, 2025.

There are few institutions that exemplify our nation’s commitment to progress and shared prosperity like the National Institutes of Health…

Scientists rally across the country in response to layoffs and funding cuts ordered by the Trump administration

The 2025 Gordon Research Conference on Mammary Gland Biology will be held in Newry, Maine. Apply today to reserve your spot.

The Nwosu Lab at Cornell leads groundbreaking research on cancer metabolism.

Select a state on the map to see the impact of NIH funding across America.

University of Chicago professor receives V Scholar Award for work on lung cancer

Pancreatic ductal adenocarcinoma (PDAC) tumors are deficient in glutamine, an amino acid that tumor cells and CAFs use to sustain their fitness. In PDAC, both cell types stimulate macropinocytosis as ...

Mitochondria are able to maintain two competing metabolic pathways—oxidative phosphorylation and the reductive synthesis of proline and ornithine—by generating two mitochondrial subpopulations that ar...

ALT: a bald man in a blue suit is making a funny face and pointing at something .

Oncogene - Methylmalonic acid induces metabolic abnormalities and exhaustion in CD8+ T cells to suppress anti-tumor immunity

Schofield et al. report that cancer cells upregulate Acod1 as a survival strategy in response to αPD-1 therapy. Acod1hi cancer cells secrete inhibitory peptides that block the activation of naive CD8+...